Deep 6 AI
Deep 6 AI, founded in 2016, uses AI and NLP to match patients to clinical trials, leveraging both structured and unstructured data to generate clinical insights and facilitate real-time patient recruitment and monitoring.
Company History
Deep 6 AI was founded in 2016 with the goal of revolutionizing clinical trial patient matching through the use of Artificial Intelligence (AI) and Natural Language Processing (NLP). Over the years, the company has developed a precision-matching software capable of analyzing both structured data, like ICD-10 codes, and unstructured data, such as physician notes and lab results.
Services
Deep 6 AI offers several advanced AI-driven solutions specifically tailored to accelerate recruitment for clinical trials. Features include real-time patient matching, precision patient counts by site and recruitment stage, and real-time monitoring of enrollment milestones. Additionally, it provides Recruitment Acceleration and RWE Generation solutions designed to match patients in real-time and mine EMR data for real-world evidence studies respectively.
Technology and Data Utilization
Deep 6 AI employs sophisticated AI and NLP technologies to search through both structured data and unstructured data, including genetic lab reports and genomics data in EMRs. The platform uses concept mapping to represent patients as graphs, generating new clinical insights. FHIR is used as the standard system for data processing, and the services are hosted on AWS, ensuring HIPAA compliance.
Real-World Applications
Working with over 1,100 sites and 8,000 researchers, Deep 6 AI enables easy patient referrals and matches patients to studies for which they qualify. It has integrated its AI solutions into provider workflows at over 25 major healthcare organizations, establishing one of the largest databases of unstructured patient data globally. This makes it possible to track clinical trial milestones in real time compared to baseline metrics.
Partnerships and Collaborations
Deep 6 AI collaborates with various stakeholders within the healthcare sector, including a notable partnership with Magnolia Market Access to accelerate real-world evidence projects. The company's precision research ecosystem connects researchers, physicians, sponsors, and CROs, ensuring seamless coordination in clinical trial projects.